Global HPV Decontamination Systems Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Fixed and Portable.

By H2O2 Concentration;

Below 20%, 20% To 40%, and Above 40%.

By Applications;

Incubators, Autoclave/Cage Washer, Isolators, and Rooms/Facilities.

By End-Use;

Hospitals & Healthcare Facilities, Pharmaceutical Manufacturing Companies, Medical Device Manufacturing Companies, Life Sciences, and Biotechnology Research Organizations.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn500917895 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global HPV Decontamination Systems Market (USD Million), 2021 - 2031

In the year 2024, the Global HPV Decontamination Systems Market was valued at USD 497.14 million. The size of this market is expected to increase to USD 789.15 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.


Global HPV Decontamination Systems Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.8 %
Market Size (2024)USD 497.14 Million
Market Size (2031)USD 789.15 Million
Market ConcentrationMedium
Report Pages368
497.14
2024
789.15
2031

Major Players

  • Bioquell, plc
  • Panasonic Biomedical Sales Europe B.V.
  • Getinge Group
  • Labotal Scientific Equipment
  • TOMI Environmental Solutions, Inc.
  • Fedegari Autoclavi SpA
  • Sterilucent, Inc.
  • Howorth Air Technology Inc.
  • Angoss Software Corporation
  • SKAN AG
  • MBRAUN

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global HPV Decontamination Systems Market

Fragmented - Highly competitive market without dominant players


The global HPV (Hydrogen Peroxide Vapor) decontamination systems market is witnessing significant growth due to the increasing emphasis on maintaining high standards of hygiene and safety across various sectors. These systems utilize hydrogen peroxide vapor to eliminate bacteria, viruses, fungi, and spores from surfaces and equipment, making them indispensable in environments where sterility is paramount. Hospitals, laboratories, and pharmaceutical manufacturing facilities are among the primary adopters of HPV decontamination systems, driven by the need to prevent healthcare-associated infections (HAIs) and ensure compliance with stringent regulatory standards.

Advancements in technology and growing awareness about the benefits of HPV decontamination systems are further propelling market growth. Modern systems are designed to be more efficient, user-friendly, and environmentally friendly, reducing the overall cycle time for decontamination processes. The integration of automation and remote monitoring capabilities in these systems enhances their operational efficiency and reliability, making them a preferred choice in critical settings. Additionally, the ongoing research and development efforts to improve the efficacy of HPV decontamination systems and their applicability across different industries are expected to create new growth opportunities.

Geographically, the market is expanding as awareness and adoption of HPV decontamination systems increase across regions. North America and Europe currently dominate the market, owing to their well-established healthcare infrastructure and stringent regulatory requirements. However, the Asia Pacific region is emerging as a lucrative market due to rapid industrialization, increasing healthcare investments, and rising awareness about infection control practices. As the demand for effective decontamination solutions continues to grow globally, the HPV decontamination systems market is poised for robust growth in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By H2O2 Concentration
    3. Market Snapshot, By Applications
    4. Market Snapshot, By End-Use
    5. Market Snapshot, By Region
  4. HPV Decontamination Systems Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Infection Control
        2. Healthcare-associated Infections (HAIs)
        3. Stringent Regulatory Standards
        4. Technological Advancements
      2. Restraints
        1. High Implementation Costs
        2. Environmental Concerns
        3. Compatibility Issues with Equipment
        4. Lack of Awareness in Developing Regions
      3. Opportunities
        1. Emerging Markets
        2. Expansion in Pharmaceutical Industry
        3. Advancements in Automation and Robotics
        4. Development of Eco-friendly Decontamination Methods
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. HPV Decontamination Systems Market, By Type, 2021 - 2031 (USD Million)
      1. Fixed
      2. Portable
    2. HPV Decontamination Systems Market, By H2O2 Concentration, 2021 - 2031 (USD Million)
      1. Below 20%
      2. 20% To 40%,
      3. Above 40%
    3. HPV Decontamination Systems Market, By Applications, 2021 - 2031 (USD Million)
      1. Incubators
      2. Autoclave/Cage Washer
      3. Isolators
      4. Rooms/Facilities
    4. HPV Decontamination Systems Market, By End-Use, 2021 - 2031 (USD Million)
      1. Hospitals & Healthcare Facilities
      2. Pharmaceutical Manufacturing Companies
      3. Medical Device Manufacturing Companies
      4. Life Sciences
      5. Biotechnology Research Organizations
    5. HPV Decontamination Systems Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bioquell, plc
      2. Panasonic Biomedical Sales Europe B.V.
      3. Getinge Group
      4. Labotal Scientific Equipment
      5. TOMI Environmental Solutions, Inc.
      6. Fedegari Autoclavi SpA
      7. Sterilucent, Inc.
      8. Howorth Air Technology Inc.
      9. Angoss Software Corporation
      10. SKAN AG
      11. MBRAUN
  7. Analyst Views
  8. Future Outlook of the Market